NCT05652335 2026-03-13A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisJanssen Research & Development, LLCPhase 1 Recruiting180 enrolled
NCT05145816 2026-02-17Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL AmyloidosisUniversity of Texas Southwestern Medical CenterPhase 1/2 Recruiting37 enrolled
NCT04991103 2025-12-31Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)University of Alabama at BirminghamPhase 2 Recruiting40 enrolled
NCT07285044 2025-12-22The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo ClinicPhase 2 Recruiting27 enrolled